首页> 外文期刊>Italian Journal of Medicine >The J curve in hypertension. Physiopathologic speculation or a relevant issue in clinical practice?
【24h】

The J curve in hypertension. Physiopathologic speculation or a relevant issue in clinical practice?

机译:高血压的J曲线。生理病理学推测或临床实践中的相关问题?

获取原文
           

摘要

Introduction: The J curve phenomenon in the treatment of hypertension refers to the view that reducing blood pressure below a certain critical point (diastolic pressure in particular) is no longer beneficial and may actually increase the risk of cardiovascular events. The existence of this phenomenon has been debated for many years. Many autors deny that it exists, at least within the range of pressure values commonly observed in clinical practice. Aim of the study: The aim of this article is to verify whether in 2010 it is still possible to talk about a J curve or whether the inverse relationship between diastolic pressure and cardiovascular events depends on pre-existent diseases. Materials and methods: The authors carried out a search of the PubMed database for articles published in 2004 or later with the following Keywords J-curve, antihypertensive treatment, and blood pressure goals. Results: Most of the studies reviewed confirmed the existence of a J curve, but the role played by serious comorbidities is still unclear. In most cases, patients with major diseases have lower blood pressures. Moreover, cardiac patients already have impairments involving the coronary circulation. It is quite obvious that these patients are more exposed to pressure drops, especially those occurring during diastole, when the vast majority of blood flow to the coronary circulation is delivered. Conclusions: A J curve certainly exists: there is obviously a threshold value under which an excessively low blood pressure can no longer guarantee adequate perfusion of vital organs. The problem lies in the identification of this threshold value. Furthermore, considering the undeniable impact on this phenomenon of concurrent diseases, timely intervention is essential to avoid transforming low-risk patients (those less likely to experience J curve-related complications) into high-risk patients (more likely to experience these complications).
机译:简介:高血压治疗中的J曲线现象是指将血压降低到某个临界点(尤其是舒张压)以下不再有好处,实际上可能增加心血管事件的风险。这种现象的存在已经争论了很多年。许多汽车制造商否认其存在,至少在临床实践中通常观察到的压力值范围内。研究的目的:本文的目的是验证在2010年是否仍然有可能讨论J曲线,或者舒张压与心血管事件之间的逆相关性是否取决于先前存在的疾病。材料和方法:作者在PubMed数据库中搜索了2004年或以后发表的具有以下关键词J曲线,抗高血压治疗和血压目标的文章。结果:大多数经审查的研究均证实存在J曲线,但严重合并症所起的作用仍不清楚。在大多数情况下,重大疾病患者的血压较低。此外,心脏病患者已经患有涉及冠状动脉循环的损伤。显然,这些患者更容易遭受压降,尤其是在舒张期发生的压降中,那时大部分血液流向了冠状动脉循环。结论:J曲线确实存在:显然存在一个阈值,在该阈值下,过低的血压不再能够确保重要器官的充分灌注。问题在于该阈值的识别。此外,考虑到对这种并发疾病现象的不可否认的影响,及时干预对于避免将低风险患者(不太可能发生J曲线相关并发症)转变为高风险患者(更可能发生这些并发症)至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号